NuVasive (NUVA +3.8%) trades up after Brean Murray initiates the shares with a Buy and a $30 price target. The firm says that with as solid a pipeline as NUVA has, expectations for the medical-device company look conservative now that it has "successfully defended" its core U.S. spinal-products business.
NuVasive (NUVA +3.8%) trades up after Brean Murray initiates the shares with a Buy and a $30...
From other sites
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
at CNBC.com (Jun 28, 2012)
at CNBC.com (Jun 23, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs